Unravelling the three-dimensional genomic structure of male germ cells Blog Post

A study led by scientists of the National Centre for Genomic Analysis (CNAG-CRG) –based in the Barcelona Science Park and integrated into the Centre for Genomic Regulation (CRG)–  and the Universitat Autònoma de Barcelona (UAB) reveals the three-dimensional genomic structure of male germ cells and how this structure determines their function. The study, published in the journal Cell Reports, represents a significant advance in our understanding of how the dynamics of insulator proteins and transcriptional activity are coupled during the 3D genome re-organisation that takes place during the formation of male germ cells.

 

The GAEM ‘Value Company’ Certification is launched Blog Post

GAEM Foundation, based in the Parc Científic de Barcelona Science Park, has launched the GAEM ‘Value Company’ Certification, recognising the most avant-garde companies committed to Corporate Social Responsibility (CSR) and social well-being. With this seal, the foundation aims to continue promoting biomedical research to cure multiple sclerosis and contribute to raising awareness of the importance of innovation and science in our society. 

 

Meteosim implements the world’s first comprehensive air quality management system in Riyadh Blog Post

Meteosim, headquartered in the Barcelona Science Park (PCB), has implemented a first-of-its-kind system in Riyadh to integrate, in a single platform, the city’s air quality forecast, atmospheric chemical emergency management and any related decision making. This is the world’s most ambitious project in this field allowing to predict the air quality in any given street in the capital city of Saudi Arabia, which has over 8 million inhabitants.

 

Scientists at IRB Barcelona can simulate and predict the shape of a molecule in function of its environment Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) at the Barcelona Science Park hows that computer simulations can predict the shape of a molecule in function of its environment. The research results, published in Angewandte Chemies, mark a milestone for the computational design of molecules with specific shape and features for agrochemical, technological and pharmaceutical applications.

 

Binucleated cells could be the key in heart regeneration Blog Post

A team of researchers, led by Xavier Trepat, from the Institute of Bioengineering of Catalonia (IBEC) in collaboration with the Centre for Regenerative Medicine in Barcelona (CMR [B]), have discovered a surprising mechanism that generates binucleated cells during the regeneration of the heart of the zebrafish, and could be associated with the extraordinary regenerative power of this animal. The results of the work has attracted the attention of researchers from all over the world, who see the range of possibilities that would be opened up if this mechanism of cell regeneration could be applied in human therapies.

 

The European project GLAM develops a multiplexed biosensor for personalized diagnosis and therapy for bladder cancers Blog Post

A European consortium led by Centre Tecnològic Leitat –through its Biomed Division in the Barcelona Science Park (PCB)– has finished the GLAM project, the aim of which was to develop a photonic biosensor for a non-invasive diagnosis and personalized therapy for bladder cancers. The project involved the participation of 10 European organizations with resources and capabilities from the academia and scientific and business field, among them the Institute for Bioengineering of Catalonia (IBEC), which is also located in PCB.

 

Record-breaking turnout at Bio€quity from the Barcelona Science Park Blog Post

On 20 and 21 May, Barcelona played host for the first time to Bio€quity Europe, the main investment event focussing on the European biopharmaceutical industry, thanks to an initiative from the Comité Anfitrión Regional (Regional Hosting Committee) comprising Biocat, CataloniaBio & HealthTech, ACCIÓ and Ysios Capital. A dozen companies from the Barcelona Science Park (PCB) were chosen by the organisation as some of the 80 most promising biotechnologies in Europe to present their project to the 550 investors, business developers and experts into biopharmaceutical licensing that attended the event.

 

GlyCardial Diagnostics wins the EmprendedorXXI 2019 Award in the ‘Health Tech’ category Blog Post

GlyCardial Diagnostics has won the  the EmprendedorXXI Award in the ‘Health Tech’ category, one of the six awards granted in its twelfth year to recognize those companies in Spain and Portugal with greatest growth potential in several sectors linked to the new innovation trends. The winners have been selected from 961 companies in Spain and Portugal. The biotechnology company, headquartered in the Barcelona Science Park, adds this award to the EmprendedorXXI Award in Catalonia, which it received on 9 May.

 

Ona Therapeutics hits the road thanks to Sabadell Asabys Blog Post

Today Ona Therapeutics, the new IRB Barcelona spin-off, announced the close of a seed funding round of € 1.5M given by Sabadell Asabys, a fund managed by Asabys Partners and devoted to investments in health innovation. With this injection of capital, the company, based in the Barcelona Science Park, will begin work on the development of a new drug for the treatment of metastatic cancer.